Reference is made to the stock exchange announcement by Ultimovacs ASA (the "Company") on 17 December 2024 regarding the agreement to combine its business with Zelluna Immunotherapy AS (the "Business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback